Back
Cencora Inc (COR)
Health CareCOR · NEW YORK STOCK EXCHANGE, INC. · USD
New to investing? How to read this page →$328.05
+1.35%Weekly undervalued picks
Price · 1 year
Loading live analysis…
Loading analysis…
Intrinsic Investor is for research and education only. Not financial advice.
Key metrics
EPS
$7.96
ROE
107.1%
Gross margin
3.8%
Debt/Equity
4.21x
Revenue growth
3.8%
Cencora Inc — company intelligence
Earnings surprises
Q3 2026$4.48 vs $4.39 est+2.0%
Q2 2026$4.75 vs $4.86 est-2.3%
Q1 2026$4.08 vs $4.08 est+0.0%
Q4 2025$3.84 vs $3.82 est+0.4%
Analyst consensus · 20 analysts
15 Buy5 Hold0 Sell
Updated Aug 24, 2026
Insider activity · 90 days
8 buys0 sellsnet +8,965 shares
Tyler Lauren MBuy 97 · Jul 31, 2026
NALLY DENNIS MBuy 113 · Jul 31, 2026
Cooper EllenBuy 97 · Jul 31, 2026
Recent SEC filings
4 — Insider transaction reportAug 25, 2026
8-K — Material event reportAug 14, 2026
8-K — Material event reportAug 12, 2026
Latest news
RBC Capital Initiates Coverage of Cencora (COR) with Sector Perform Recommendation — Fintel · 6d ago
$100 Invested In Cencora 10 Years Ago Would Be Worth This Much Today — Benzinga · 6d ago
RBC Capital Initiates Coverage On Cencora with Sector Perform Rating, Announces Price Target of $330 — Benzinga · 6d ago
5 Insightful Analyst Questions From Cencora’s Q2 Earnings Call — Yahoo · 1w ago
AI Valuation Narrative
Generates a short bull / bear / catalyst summary from the analytics we already computed. No target prices. Research tool, not investment advice.
Explore more
Peers & similar stocks
Quick links to related tickers for research.
Weekly undervalued picks
Get 3 new value ideas and the fair-value math behind them every week. One email, unsubscribe anytime.
Free. No spam. We only email once per week.
Data is provided "as-is" and may be delayed or incomplete. Intrinsic Investor is for education only and is not investment advice.